Two Sigma Advisers Portfolio holdings
AUM
$48.8B
1-Year Return
29.82%
This Quarter Return
+3.47%
1 Year Return
+29.82%
3 Year Return
+107.12%
5 Year Return
+201.81%
10 Year Return
+492.86%
AUM
$40.2B
AUM Growth
+$524M
(+1.3%)
Cap. Flow
-$136M
Cap. Flow
% of AUM
-0.34%
Top 10 Holdings %
Top 10 Hldgs %
11.4%
Holding
2,549
New
274
Increased
913
Reduced
1,082
Closed
255
Top Buys
| 1 |
Costco
COST
|
+$325M |
| 2 |
Johnson & Johnson
JNJ
|
+$306M |
| 3 |
Amazon
AMZN
|
+$278M |
| 4 |
Visa
V
|
+$194M |
| 5 |
Electronic Arts
EA
|
+$183M |
Top Sells
| 1 |
Tesla
TSLA
|
+$243M |
| 2 |
Target
TGT
|
+$228M |
| 3 |
Chipotle Mexican Grill
CMG
|
+$224M |
| 4 |
Comcast
CMCSA
|
+$203M |
| 5 |
TJX Companies
TJX
|
+$202M |
Sector Composition
| 1 | Consumer Discretionary | 17.25% |
| 2 | Technology | 17% |
| 3 | Healthcare | 15.39% |
| 4 | Industrials | 11.71% |
| 5 | Financials | 8.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BEAT
1326
DELISTED
BioTelemetry, Inc.
BEAT
| $1.53M | ﹤0.01% |
31,800
+16,100
| +103% | +$775K |
|
|
ATCO
1327
DELISTED
Atlas Corp.
ATCO
| $1.53M | ﹤0.01% |
155,900
-2,300
| -1% | -$22.6K |
|
|
GNMK
1328
DELISTED
GenMark Diagnostics, Inc
GNMK
| $1.52M | ﹤0.01% |
234,600
+17,700
| +8% | +$115K |
|
1329
Northwest Bancshares
NWBI
$1.85B
| $1.52M | ﹤0.01% |
86,300
-55,350
| -39% | -$975K |
|
1330
Protagonist Therapeutics
PTGX
$3.71B
| $1.51M | ﹤0.01% |
125,000
+31,200
| +33% | +$378K |
|
|
SWCH
1331
DELISTED
Switch, Inc. Class A Common Stock
SWCH
| $1.51M | ﹤0.01% |
115,465
+41,100
| +55% | +$538K |
|
1332
Camtek
CAMT
$3.84B
| $1.5M | ﹤0.01% |
177,500
+45,800
| +35% | +$387K |
|
|
QADA
1333
DELISTED
QAD Inc.
QADA
| $1.5M | ﹤0.01% |
37,300
+200
| +0.5% | +$8.04K |
|
1334
PotlatchDeltic
PCH
$3.3B
| $1.5M | ﹤0.01% |
38,368
-26,000
| -40% | -$1.01M |
|
|
VSM
1335
DELISTED
Versum Materials, Inc.
VSM
| $1.5M | ﹤0.01% |
29,000
-171,500
| -86% | -$8.85M |
|
|
CHS
1336
DELISTED
Chicos FAS, Inc.
CHS
| $1.49M | ﹤0.01% |
441,640
-78,200
| -15% | -$263K |
|
1337
Abbott
ABT
$231B
| $1.48M | ﹤0.01% |
+17,600
| New | +$1.48M |
|
1338
Darling Ingredients
DAR
$5.05B
| $1.48M | ﹤0.01% |
74,200
-8,259
| -10% | -$164K |
|
|
BCOV
1339
DELISTED
Brightcove, Inc.
BCOV
| $1.47M | ﹤0.01% |
142,576
-19,200
| -12% | -$198K |
|
|
HCCI
1340
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
| $1.47M | ﹤0.01% |
55,983
-3,600
| -6% | -$94.7K |
|
1341
Rigel Pharmaceuticals
RIGL
$677M
| $1.47M | ﹤0.01% |
56,239
+5,000
| +10% | +$131K |
|
1342
SpartanNash
SPTN
$898M
| $1.46M | ﹤0.01% |
125,427
+34,300
| +38% | +$400K |
|
1343
NeoGenomics
NEO
$1.08B
| $1.46M | ﹤0.01% |
66,600
-40,000
| -38% | -$877K |
|
1344
Radiant Logistics
RLGT
$308M
| $1.46M | ﹤0.01% |
237,400
+63,300
| +36% | +$389K |
|
|
ATRS
1345
DELISTED
Antares Pharma, Inc.
ATRS
| $1.45M | ﹤0.01% |
441,532
+49,000
| +12% | +$161K |
|
1346
Ares Management
ARES
$40.5B
| $1.45M | ﹤0.01% |
+55,300
| New | +$1.45M |
|
1347
ICF International
ICFI
$1.82B
| $1.45M | ﹤0.01% |
19,848
+4,804
| +32% | +$350K |
|
1348
Trustco Bank Corp NY
TRST
$755M
| $1.45M | ﹤0.01% |
36,487
-6,500
| -15% | -$257K |
|
1349
CBRE Group
CBRE
$49.4B
| $1.44M | ﹤0.01% |
28,000
-206,400
| -88% | -$10.6M |
|
1350
Parker-Hannifin
PH
$97.6B
| $1.44M | ﹤0.01% |
8,446
-122,859
| -94% | -$20.9M |
|